145 related articles for article (PubMed ID: 37783458)
1. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.
Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S
Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of nasopharyngeal
Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
[TBL] [Abstract][Full Text] [Related]
3. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.
Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM
N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084
[TBL] [Abstract][Full Text] [Related]
4. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T;
PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718
[TBL] [Abstract][Full Text] [Related]
5. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).
O'Brien KS; Arzika AM; Amza A; Maliki R; Ousmane S; Kadri B; Nassirou B; Mankara AK; Harouna AN; Colby E; Lebas E; Liu Z; Le V; Nguyen W; Keenan JD; Oldenburg CE; Porco TC; Doan T; Arnold BF; Lietman TM;
BMC Public Health; 2021 Apr; 21(1):822. PubMed ID: 33926403
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.
Hare KM; Grimwood K; Chang AB; Chatfield MD; Valery PC; Leach AJ; Smith-Vaughan HC; Morris PS; Byrnes CA; Torzillo PJ; Cheng AC
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2275-85. PubMed ID: 26363637
[TBL] [Abstract][Full Text] [Related]
7. Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control.
Bojang E; Jafali J; Perreten V; Hart J; Harding-Esch EM; Sillah A; Mabey DC; Holland MJ; Bailey RL; Roca A; Burr SE
BMC Microbiol; 2017 Mar; 17(1):75. PubMed ID: 28351345
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial.
Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM;
Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
Skalet AH; Cevallos V; Ayele B; Gebre T; Zhou Z; Jorgensen JH; Zerihun M; Habte D; Assefa Y; Emerson PM; Gaynor BD; Porco TC; Lietman TM; Keenan JD
PLoS Med; 2010 Dec; 7(12):e1000377. PubMed ID: 21179434
[TBL] [Abstract][Full Text] [Related]
10. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
[TBL] [Abstract][Full Text] [Related]
11. Macrolide Resistance in MORDOR I - A Cluster-Randomized Trial in Niger.
Doan T; Arzika AM; Hinterwirth A; Maliki R; Zhong L; Cummings S; Sarkar S; Chen C; Porco TC; Keenan JD; Lietman TM;
N Engl J Med; 2019 Jun; 380(23):2271-2273. PubMed ID: 31167060
[No Abstract] [Full Text] [Related]
12. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
[TBL] [Abstract][Full Text] [Related]
13. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.
Arzika AM; Maliki R; Boubacar N; Kane S; Cotter SY; Lebas E; Cook C; Bailey RL; West SK; Rosenthal PJ; Porco TC; Lietman TM; Keenan JD;
PLoS Med; 2019 Jun; 16(6):e1002835. PubMed ID: 31237871
[TBL] [Abstract][Full Text] [Related]
14. Effect of Biannual Azithromycin to Children under 5 Years on the Carriage of Respiratory Pathogens among Children Aged 7-11 Years.
Brennhofer SA; Rogawski McQuade ET; Zhang J; Pholwat S; Stroup S; Platts-Mills JA; Liu J; Houpt ER
Am J Trop Med Hyg; 2023 Feb; 108(2):428-432. PubMed ID: 36535258
[TBL] [Abstract][Full Text] [Related]
15. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
[TBL] [Abstract][Full Text] [Related]
16. Long-term Impact of Oral Azithromycin Taken by Gambian Women During Labor on Prevalence and Antibiotic Susceptibility of Streptococcus pneumoniae and Staphylococcus aureus in Their Infants: Follow-up of a Randomized Clinical Trial.
Bojang A; Camara B; Jagne Cox I; Oluwalana C; Lette K; Usuf E; Bottomley C; Howden BP; D'Alessandro U; Roca A
Clin Infect Dis; 2018 Sep; 67(8):1191-1197. PubMed ID: 29608659
[TBL] [Abstract][Full Text] [Related]
17. Increase of Macrolide-Resistance in
Gonzales BE; Mercado EH; Pinedo-Bardales M; Hinostroza N; Campos F; Chaparro E; Del Águila O; Castillo ME; Saenz A; Reyes I; Ochoa TJ
Front Cell Infect Microbiol; 2022; 12():866186. PubMed ID: 35615398
[No Abstract] [Full Text] [Related]
18. Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx.
Gladstone RA; Bojang E; Hart J; Harding-Esch EM; Mabey D; Sillah A; Bailey RL; Burr SE; Roca A; Bentley SD; Holland MJ
Clin Microbiol Infect; 2021 Jun; 27(6):864-870. PubMed ID: 32750538
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin.
Djamin RS; Talman S; Schrauwen EJA; von Wintersdorff CJH; Wolffs PF; Savelkoul PHM; Uzun S; Kerstens R; van der Eerden MM; Kluytmans JAJW
Antimicrob Resist Infect Control; 2020 Jul; 9(1):116. PubMed ID: 32723393
[TBL] [Abstract][Full Text] [Related]
20. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.
Malhotra-Kumar S; Lammens C; Coenen S; Van Herck K; Goossens H
Lancet; 2007 Feb; 369(9560):482-90. PubMed ID: 17292768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
